Zelys Chew Tablets 1.25mg
CEVA ANIMAL HEALTH
Zelys Chew Tablets 1.25mg from CEVA ANIMAL HEALTH is supplied as a chewable tablet.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Pimobendan
Pack & Presentation
Form: Chewable tablet · Pack size: PK 96
Suitable Species
Dogs
Indications
For the treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid valve regurgitation) or dilated cardiomyopathy.
Storage & Shelf Life
For blisters: Any unused tablet portion should be returned to the blister and be used for the next administration. Do not store above 30 °C. For bottle: Keep the bottle tightly closed in order to protect from moisture.
Owner Handling & Safety
Accidental ingestion, especially by a child, may lead to the occurrence of tachycardia, orthostatic hypotension, flushing of the face and headaches. Unused part-tablets should be returned to the open blister space, or to the bottle and inserted back into the outer packaging. Keep in a safe place out of the sight and reach of children.
Contraindications & Warnings
Do not use pimobendan in hypertrophic cardiomyopathies or in diseases in which an improvement in cardiac output cannot be achieved for functional or anatomical reasons (e.g. aortic stenosis). Since pimobendan is metabolised mainly via the liver, it should not be used in dogs with severe impairment of liver function (see also Use during pregnancy, lactation or lay).
Use in Pregnancy & Lactation
Laboratory studies in rats and rabbits have not produced any evidence of teratogenic or foetotoxic effects. However, these studies have shown evidence of maternotoxic and embryotoxic effects at high doses, and have also shown that pimobendan is excreted into milk.
Regulatory Information
- Legal category: POM-V
- MA number: 1.25 mg: GB Vm 14966/5085 NI Vm 14966/3084 5 mg: GB Vm 14966/5086 NI Vm 14966/3085 10 mg: GB Vm 14966/5087 NI Vm 14966/3086
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
